Susquehanna Fundamental Investments, LLC Myovant Sciences Ltd. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$11.38 - $16.4 $117,862 - $169,854	-10,357 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$14.31 - $23.87 $34,959 - $58,314	-2,443 Reduced 19.09%	10,357 $161,000
Q3 2021 Nov 15, 2021	BUY	$18.94 - $26.99 $242,432 - $345,472	12,800 New	12,800 $287,000
Q2 2021 Aug 11, 2021	SELL	$17.07 - $24.56 $206,547 - $297,176	-12,100 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.34 - $20.84 $88,814 - $252,164	12,100 New	12,100 $250,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.